Collin D. Morris,Fritz Blatter,Giuseppe Lapadula,Stefan Reim,Michael Burgert,Erik Philipp
申请号：
US16603904
公开号：
US20200113885A1
申请日:
2018.04.18
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The invention relates to novel salts of compounds of the general formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia, sickle cell disease and hemochromatosis.
